Page results
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
This page provides general information about care of wounds following spinal surgery.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
The function to book blood test appointments will soon be transferred from MyCare to Swiftqueue. Target go-live date: 27th June
-
Information about the EGA Hospital Charity at UCLH
-
This page provides information for patients planning or considering a homebirth with UCLH.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided Caudal Epidural injections to patients referred by the Camden community MSK services.
-
Patient information for women who have chosen to have surgical management under general anaesthetic following a diagnosis of a miscarriage.
File results
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0392 - Treatment/ medication for biologic medicines in gastroenterology
-
FOI/2023/0394 - Business continuity plans for telecommunications system/ bleep/ switchboard
-
FOI/2023/0396 - Compensation paid for maternity claims 2022/23
-
FOI/2023/0399 - Patient deaths while waiting to receive planned care/ patients waiting more than 18 weeks - 2022
-
FOI/2023/0401 - Patient treatments for brain tumour from 2018-2022
-
FOI/2023/0402 - Migraine treatment/ medication